Models made for science at University of Sydney exhibition
26 February, 2013An exhibition at the University of Sydney’s Macleay Museum provides a rare opportunity to see models used to teach science and medicine at the university from the 1880s.
Bone Therapeutics invests in cell therapy manufacturing facility
26 February, 2013Bone Therapeutics, an international biopharmaceutical company focused on innovative cell therapy products for the treatment of bone diseases, has announced that it has secured its future manufacturing requirements, allowing it to produce its bone cell therapy products on a commercial scale.
New workforce development service will help SMEs improve their competitive edge
25 February, 2013A Manufacturing Workforce Development Service (MWDS) has been formed to specifically work with manufacturing SMEs to support and help them access the Australian government’s National Workforce Development Fund (NWDF).
NSW Government funding for researchers competing for Commonwealth grants
25 February, 2013Deputy Premier and Minister for Trade & Investment Andrew Stoner is urging NSW’s leading research centres to tap into state government funding offering them a more competitive edge in attracting lucrative Commonwealth grants.
Neurotrauma research to benefit from development grants
20 February, 2013Twelve new research projects focusing on improving outcomes for Transport Accident Commission (TAC) and WorkSafe Victoria clients have been funded through the Institute for Safety, Compensation and Recovery Research (ISCRR) 2013 Development Grants Program.
UWA becomes a global online classroom
19 February, 2013The first free online courses in arts and science are about to be offered at The University of Western Australia in collaboration with US internet-study pioneer Stanford University.
Trans-Tasman action to fast-track rheumatic fever vaccine
18 February, 2013The University of Western Australia and the Telethon Institute for Child Health Research have welcomed a commitment by the Australian and New Zealand Prime Ministers to fast-track the development of a vaccine against rheumatic fever.
Academy awards excellence in science
18 February, 2013The Australian Academy of Science today opened applications for its 2014 round of prestigious awards, including career and early career researcher awards, travelling fellowships, research bursaries and conference support.
Investment boosts new start-up’s plans to develop autoimmune drugs
15 February, 2013The University of Technology, Sydney’s (UTS) ithree institute has launched Helmedix with a $1.25 million investment from Australia’s Medical Research Commercialisation Fund (MRCF).
Breakthrough actions for innovation released
15 February, 2013Australia’s Chief Scientist Professor Ian Chubb has released five breakthrough actions governments could take to make Australia a more innovative nation. They include the establishment of an Australian Innovation Council and helping business access publicly funded research.
Science Academy welcomes hazard research funding
15 February, 2013The Australian Academy of Science has welcomed the announcement by Prime Minister Julia Gillard and Science Minister Chris Bowen of new funding for bushfire and natural hazard research through the Cooperative Research Centres (CRCs).
Qiagen and Lilly to collaborate on the development of companion diagnostics
14 February, 2013Qiagen has entered into a master collaboration agreement with Eli Lilly and Company for the development and commercialisation of companion diagnostics for pairing with Lilly investigational and approved medicines across all therapeutic areas.
Optibrium and Lhasa collaborate to bring expert toxicity prediction to chemists’ desktops
13 February, 2013Optibrium and Lhasa, providers of software for compound design, selection and property prediction, have announced a technology collaboration agreement.
Sigma Life Science to distribute Olink Bioscience’s protein interaction analysis technology
13 February, 2013Sigma-Aldrich Corporation has announced that Sigma Life Science, its innovative biological products and services business, has signed an agreement to distribute worldwide Olink Bioscience’s Duolink In Situ products, which present a disruptive method for imaging and measuring protein-protein interactions in unmodified cells.
Wollongong to host world-leading scientists for symposium
12 February, 2013More than 150 leading Australian and international researchers will converge on Wollongong this week to speak about and share insights into groundbreaking materials research as part of the 8th Annual International Electromaterials Science Symposium.
